MedTrace Logo

Dog Hair Extract Study

NCT01343420 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2021-01-19

No results posted yet for this study

Summary

Liquid allergen extracts contain proteins, such as (but not limited to) tree, weed, cat, cockroach, and nuts, and are used to identify allergies by observing the body's reaction to the introduction of extract underneath the skin. There are a few dog allergen extracts commercially available in the US for allergy testing; however, none of these products are standardized, meaning they are not required to be the same strength. Because some extracts are not as potent (strong) as others, it's possible that some patients' allergies are misdiagnosed. Typically, the most potent (strong), but safe extract should be used so that allergic patients are correctly diagnosed.

The purpose of this study is to compare the safety and potency of an investigational (not approved for use by the United States Food and Drug Administration \[FDA\]) dog allergen extract with two commercially available dog extracts, which are of differing potencies.

Conditions

  • Potency of Dog Hair Extract

Interventions

BIOLOGICAL

Dog Hair Extract, ALK-Abelló, Inc.

ALK-Abelló dog epithelial 1:10w/v glycerin

Sponsors & Collaborators

  • ALK-Abelló A/S

    collaborator INDUSTRY

  • National Jewish Health

    lead OTHER

Principal Investigators

  • Harold Nelson, M.D. · National Jewish Health

Study Design

Allocation
NA
Purpose
OTHER
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01343420 on ClinicalTrials.gov